San Diego, CA (PRWEB) February 28, 2012 Parity Computing, Inc., the leader in intelligent automation solutions for the science, technology, and medical (STM) industry, has been awarded a patent by the U.S. Patent and Trademark Office for its Semantic Profiling Engine™. The patent, “System and Method for Matching and Assembling Records,” covers an invention related to assigning meaning to an untagged entity in a network of data by automatically inferring semantics from other entities in the network.
Semantic analysis is a core part of Parity’s approach to deriving insights from large, heterogeneous, and often unstructured data sets. Parity’s Semantic Profiling Engine™ – applied to data such as corpora of scientific and medical literature, business documents, and clinical records – enables applications ranging from automated profiles of scientists to journal and article recommendations to clinical decision support.
“We’re excited to have the innovation of our R&D team recognized and protected by the USPTO, and to continue to bring competitive advantage to our customers by leveraging this technology in our solutions”, said Steve Nathan, CEO of Parity Computing
Over 95% of the digital universe is unstructured data, so making sense of it is important for decision makers in business, science, medicine, and government. Parity’s proprietary algorithms dynamically examine the relationships among all pieces of available data in order to ascribe the most context-appropriate meaning to each piece.
“When creating applications that will drive our customers’ critical decisions, accuracy is paramount”, said Dr. Christopher Rosin, Parity’s Chief Scientist and co-founder. “The combination of our accuracy-driven development methodology and approach for analyzing explicit and derived semantic information provides the basis for the industry leading performance of our solutions.”
About Parity Computing
Parity provides powerful data mining, analytics, and decision-support systems to publishers and enterprises in the science, technology, and medical (STM) industry. Additionally, Parity’s Clinical Vigilance™ product line monitors disparate healthcare data sources to create better patient outcomes at lower costs by providing evidence-based, disease-specific clinical decision support.